• Mike Lampron to step down as Managing Director & CEO effective 30 June 2025
• Teri Thomas appointed as incoming Managing Director & CEO, commencing 1 July 2025
• Teri Thomas has extensive experience in healthcare technology and executive leadership

Mach7 Technologies Limited ('Mach7' or the 'Company') (ASX:M7T), a company specialising in innovative medical imaging software solutions, today announces that Mike Lampron will be stepping down as Managing Director & Chief Executive Officer, effective 30 June 2025. The Board has appointed Teri Thomas as incoming Managing Director & CEO, commencing on 1 July 2025. Mach7 Chair Robert Bazzani acknowledged Mike Lampron's significant contribution to the company since joining in 2017, and stated that he leaves Mach7 in a strong financial position. The Board is delighted to welcome Teri Thomas as the new CEO, noting her drive, energy, deep operational and turnaround experience in healthcare technology, and strategic leadership, which will be invaluable as Mach7 continues to execute its growth strategy and maximise shareholder value. Teri Thomas has a distinguished career in healthcare technology and executive leadership, including roles as CEO of Volpara Health Technologies Ltd and Chief Business Officer of Lunit. She has extensive experience across global markets and a proven track record of driving strategic growth, making her well positioned to lead Mach7 in its mission to revolutionise healthcare imaging through innovation and strategic execution.